AEON Biopharma, Inc. Capital Expenditures
AEON Biopharma, Inc. (AEON) reported Capital Expenditures of $4.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-12
- AEON Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
- AEON Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- AEON Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $0.00.
- AEON Biopharma, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $4.00K.
- AEON Biopharma, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $4.00K.
- AEON Biopharma, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $306.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $4.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | $4.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $4.00K 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-14 | |||
| 2022-12-31 | $9.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | $306.00K 10-K/A · filed 2024-05-14 | ||
| 2022-09-30 | $297.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |